Pioglitazone

Pioglitazone Related Compound B Pioglitazone RC B:

5-(4-(2-(5-Ethyl-6-(4-(2-(5-ethylpyridin-2-yl)ethoxy)phenyl)pyridine-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione ; CAS : 669716-56-7 ; C34H35N3O4S ; MW: 581.72 ;
 

Pioglitazone EP Impurity B

 Pioglitazone Impurity B:

5-{4-[2-(5-Ethyl-2-pyridinyl) ethoxy] benzylidene}-2,4-thiazolidinedione ;

CAS : 144809-28-9 ;  C19H18N2O3S ; MW: 354.42 ;
Pioglitazone EP Impurity C Pioglitazone Impurity C:

5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-N-[2-(5-ethylpyridin-2-yl)ethyl]-2,4-thiazolidinedione ; CAS : 952188-00-0 ; C28H31N3O3S ; MW: 489.63 ;
Pioglitazone EP Impurity D Pioglitazone Impurity D:

Ethyl (2RS)-2-(carbamoylsulphanyl)-3-[4-[2-(5-ethylpyridin-2-yl) ethoxy] phenyl] propanoate ; CAS :868754-41-0 ; C21H26N2O4S ; MW: 402.51 ;
Pioglitazone EP Impurity E Pioglitazone Impurity E:

Ethyl 3-[4-[2-(5-Ethylpyridin-2-yl) ethoxy] phenyl] propanoate ;CAS : 868754-42-1 ;

C20H25NO3 ; MW: 327.42 ;
Pioglitazone EP Impurity F Pioglitazone Impurity F:

bis[4-(5-Thiazolidinedion-yl)methylphenyl] ether ;

5-(4-[4-(5-Thiazolidinedion-yl)methylphenoxy]benzyl) thiazolidine-2,4-dione ;

CAS : 1391052-15-5 ; C20H16N2O5S2 ; MW: 428.48 ;
Pioglitazone EP Impurity G Pioglitazone Impurity G:

5-(4-[2-(5-Ethylpyridin-2-yl)ethoxy]-3-(4-(2-(3-ethylpyridin-6-yl)ethoxy) phenyl) benzyl)thiazolidine-2,4-dione ; CAS : 952187-99-4 ; C34H35N3O4S ; MW: 581.72 ;
Pioglitazone N-Oxide Pioglitazone N-Oxide:

5-[[4-[2-(5-Ethyl-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione N-oxide ; CAS : 145350-09-0 ;  C19H20N2O4S ; MW: 372.44 ;